In individuals with implant overdentures: A randomized controlled trial
Samer Mostafa Ali, Ahmed Yaseen Alqutaibi, [...], and Dina Mohamed Elawady
Reference
(Ref ID): PMC8665162
Chosen Image filename: PMC8665162_Figure_02.jpg
Document structure and format:
Title: Summary of Research Paper on “Botulinum toxin and occlusal splints for the management of sleep bruxism in individuals with implant overdentures: A randomized controlled trial”
I. Introduction
This research paper examines the effectiveness of botulinum toxin (BTX) and occlusal splints in managing sleep bruxism (SB) in individuals with implant overdentures. The study addresses the need for improved treatment options for bruxer patients with implant overdentures and explores the potential benefits of BTX injection as a management strategy for bruxism. The main research question is whether BTX administration or occlusal splints are more effective in managing SB.
II. Methodology
The study utilized a randomized controlled trial design. Forty-two patients with definite bruxism and implant-retained overdentures were randomly assigned to three groups: a control group, a group managed with conventional occlusal stents, and a group receiving BTX injections. Patient satisfaction and sleep quality were assessed at different time intervals during a 12-month treatment period using the Pittsburgh Sleep Quality Index (PSQI) and Temporomandibular disorders/numeric scales (TMD/NS). Prosthodontic complications were also recorded.
III. Results
The results of the study showed that the group receiving BTX injections exhibited a statistically significant improvement in patient satisfaction and sleep quality compared to the other two groups. This improvement was observed throughout the 3, 6, 9, and 12-month follow-up periods. The control group had the highest number of prosthodontic complications.
IV. Discussion
The findings of this study suggest that both BTX injections and occlusal splints effectively improve patient satisfaction and sleep quality in bruxer patients with single arch implant overdentures. The use of BTX injections, in particular, offers advantages such as not relying on patient compliance and providing a 24-hour effect. However, concerns about injection and possible complications have limited the widespread use of BTX as a management strategy. The study emphasizes the need for further research on the effects of bruxism on removable prosthesis.
V. Conclusion
In conclusion, this research paper provides evidence that BTX injections and occlusal splints are effective in improving patient satisfaction and sleep quality in individuals with implant overdentures. The study contributes to the field by highlighting the potential benefits of BTX injection as a management strategy for sleep bruxism. Further research is needed to address limitations and explore the long-term effects of these interventions.
Comments